Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Immunol Lett ; 214: 45-51, 2019 10.
Article in English | MEDLINE | ID: mdl-31491433

ABSTRACT

Melatonin has protective effects against inflammation but its role in epididymitis is unknown. We addressed this in the present study using lipopolysaccharide (LPS)-stimulated sheep epididymal epithelial cells as an in vitro inflammation model. We found that interleukin (IL)-1ß, IL-6, tumor necrosis factor α, and cyclooxygenase (COX)-2 mRNA levels; COX-2 and Toll-like receptor (TLR)-4 protein levels; and nuclear factor (NF)-κB p65 phosphorylation were increased by LPS treatment. These effects were reversed in a dose-dependent manner by melatonin (10-11-10-7 M). Quantitative reverse transcription PCR and immunofluorescence analyses showed that the melatonin receptors MT1 and MT2 were expressed in sheep epididymal epithelial cells. The inhibitory effect of melatonin on inflammation was abrogated by the MT1 and MT2 receptor antagonist luzindole and the MT2 ligand 4-phenyl-2-propanamide tetraldehyde. Thus, melatonin exerted anti-inflammatory effect in epididymal epithelial cells by inhibiting TLR4/NF-κB signaling, suggesting its potential as an effective drug for the treatment of epididymitis in sheep.


Subject(s)
Epididymitis/prevention & control , Epithelial Cells/immunology , Lipopolysaccharides/toxicity , Signal Transduction/drug effects , Animals , Cells, Cultured , Cytokines/immunology , Epididymis/immunology , Epididymis/pathology , Epididymitis/chemically induced , Epididymitis/immunology , Epididymitis/pathology , Epithelial Cells/pathology , Male , Receptor, Melatonin, MT1/immunology , Receptor, Melatonin, MT2/immunology , Sheep , Signal Transduction/immunology , Toll-Like Receptor 4/immunology , Transcription Factor RelA/immunology
2.
Dokl Biochem Biophys ; 484(1): 13-16, 2019 May.
Article in English | MEDLINE | ID: mdl-31012003

ABSTRACT

We investigated the role of epiphyseal hormone melatonin in the differentiation of naive CD4+ T cells into regulatory T cells (Treg). The hormone at physiological and pharmacological concentrations inhibited Treg differentiation, decreasing both the proportion of CD4+FOXP3+ cells in the culture and the level of TGF-ß, the key cytokine for this T cell subpopulation. The inhibitory effect of exogenous melatonin was due to its interaction with the membrane receptors MT1 and MT2. At the same time, the signals realized through RORα-the nuclear receptor for melatonin-stimulated Treg formation; however, they were considerably weaker than the signals from the membrane receptors and were overlapped by the latter. Since the Treg subpopulation plays an important role in physiological and pathological processes in the body, the revealed effects of melatonin should be taken into account in its therapeutic use.


Subject(s)
Cell Differentiation/drug effects , Melatonin/pharmacology , T-Lymphocytes, Regulatory/immunology , Adult , Cell Differentiation/immunology , Female , Humans , Nuclear Receptor Subfamily 1, Group F, Member 1/immunology , Receptor, Melatonin, MT1/immunology , Receptor, Melatonin, MT2/immunology , T-Lymphocytes, Regulatory/cytology , Transforming Growth Factor beta/immunology
3.
J Pineal Res ; 66(2): e12540, 2019 Mar.
Article in English | MEDLINE | ID: mdl-30475390

ABSTRACT

Melatonin receptors play important roles in the regulation of circadian and seasonal rhythms, sleep, retinal functions, the immune system, depression, and type 2 diabetes development. Melatonin receptors are approved drug targets for insomnia, non-24-hour sleep-wake disorders, and major depressive disorders. In mammals, two melatonin receptors (MTRs) exist, MT1 and MT2 , belonging to the G protein-coupled receptor (GPCR) superfamily. Similar to most other GPCRs, reliable antibodies recognizing melatonin receptors proved to be difficult to obtain. Here, we describe the development of the first monoclonal antibodies (mABs) for mouse MT1 and MT2 . Purified antibodies were extensively characterized for specific reactivity with mouse, rat, and human MT1 and MT2 by Western blot, immunoprecipitation, immunofluorescence, and proximity ligation assay. Several mABs were specific for either mouse MT1 or MT2 . None of the mABs cross-reacted with rat MTRs, and some were able to react with human MTRs. The specificity of the selected mABs was validated by immunofluorescence microscopy in three established locations (retina, suprachiasmatic nuclei, pituitary gland) for MTR expression in mice using MTR-KO mice as control. MT2 expression was not detected in mouse insulinoma MIN6 cells or pancreatic beta-cells. Collectively, we report the first monoclonal antibodies recognizing recombinant and native mouse melatonin receptors that will be valuable tools for future studies.


Subject(s)
Antibodies, Monoclonal/immunology , Antibody Specificity/immunology , Receptor, Melatonin, MT1/analysis , Receptor, Melatonin, MT2/analysis , Animals , Mice , Protein Domains , Receptor, Melatonin, MT1/immunology , Receptor, Melatonin, MT2/immunology
4.
Bull Exp Biol Med ; 164(4): 462-465, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29504099

ABSTRACT

We studied the role of endogenous melatonin in the development and functioning of T cells that produce IL-17 (Th17) and regulatory T cells (Treg) during pregnancy. The study was performed ex vivo and in vitro with auto-serum as the source of endogenous melatonin under conditions of blockade of melatonin-dependent signaling. Participation of the hormone in the regulation of differentiation of both CD4+RORγt+ and CD4+FoxP3+T cells and their key products IL-17A and TGF-ß was demonstrated. It is known that the normal gestational process is accompanied by a decrease in Th17/Treg ratio due to hormonal changes. The sensitivity of the studied subpopulations to melatonin during pregnancy can affect its outcome.


Subject(s)
Forkhead Transcription Factors/immunology , Gene Expression Regulation/immunology , Interleukin-17/immunology , Melatonin/metabolism , T-Lymphocytes, Regulatory/immunology , Th17 Cells/immunology , Adult , Cell Differentiation/drug effects , Female , Forkhead Transcription Factors/genetics , Humans , Immune Sera/chemistry , Immune Sera/pharmacology , Immunophenotyping , Interleukin-17/genetics , Melatonin/immunology , Nuclear Receptor Subfamily 1, Group F, Member 3/genetics , Nuclear Receptor Subfamily 1, Group F, Member 3/immunology , Pregnancy , Pregnancy Trimester, First , Pregnancy Trimester, Third , Receptor, Melatonin, MT1/genetics , Receptor, Melatonin, MT1/immunology , Receptor, Melatonin, MT2/genetics , Receptor, Melatonin, MT2/immunology , Signal Transduction , T-Lymphocytes, Regulatory/cytology , T-Lymphocytes, Regulatory/drug effects , Th17 Cells/cytology , Th17 Cells/drug effects , Transforming Growth Factor beta/genetics , Transforming Growth Factor beta/immunology
5.
Zebrafish ; 14(4): 387-389, 2017 08.
Article in English | MEDLINE | ID: mdl-28318435

ABSTRACT

Antibodies raised against mammalian proteins may exhibit cross-reactivity with zebrafish proteins, making these antibodies useful for fish studies. However, zebrafish may express multiple paralogues of similar sequence and size, making them difficult to distinguish by traditional Western blot analysis. To identify the zebrafish proteins that are recognized by an antimammalian antibody, we developed a system to screen putative epitopes by cloning the sequences between the yeast SUMO protein and a C-terminal 6xHis tag. The recombinant fusion protein was expressed in Escherichia coli and analyzed by Western blot to conclusively identify epitopes that exhibit cross-reactivity with the antibodies of interest. This approach can be used to determine the species cross-reactivity and epitope specificity of a wide variety of peptide antigen-derived antibodies.


Subject(s)
Antibodies/immunology , Epitope Mapping/methods , Zebrafish Proteins/immunology , Zebrafish/immunology , Amino Acid Sequence , Animals , Antibody Specificity , Blotting, Western , Histidine/chemistry , Histidine/metabolism , Humans , Receptor, Melatonin, MT1/immunology , Receptor, Melatonin, MT2/immunology , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/immunology , Recombinant Fusion Proteins/metabolism , Sequence Homology , Small Ubiquitin-Related Modifier Proteins/genetics , Small Ubiquitin-Related Modifier Proteins/metabolism
6.
J Immunol Methods ; 428: 37-41, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26657944

ABSTRACT

Antibodies (Abs) specific to cell-surface receptors are attractive tools for studying the physiological role of such receptors or for controlling their activity. We sought to obtain such antibodies against the type 1 receptor for melatonin (MT1). For this, we injected mice with CHO cells transfected with a plasmid encoding human MT1 (CHO-MT1-h), in the presence or absence of an adjuvant mixture containing Alum and CpG1018. As we previously observed that the immune response to a protein antigen is increased when it is coupled to a fusion protein, called ZZTat101, we also investigated if the association of ZZTat101 with CHO-MT1-h cells provides an immunogenic advantage. We measured similar levels of anti-CHO and anti-MT1-h Ab responses in animals injected with either CHO-MT1-h cells or ZZTat101/CHO-MT1-h cells, with or without adjuvant, indicating that neither the adjuvant mixture nor ZZTat101 increased the anti-cell immune response. Then, we investigated whether the antisera also recognized murine MT1 (MT1-m). Using cloned CHO cells transfected with a plasmid encoding MT1-m, we found that antisera raised against CHO-MT1-h cells also bound the mouse receptor. Altogether our studies indicate that immunizing approaches based on MT1-h-expressing CHO cells allow the production of polyclonal antibodies against MT1 receptors of different origins. This paves the way to preparation of MT1-specific monoclonal antibodies.


Subject(s)
Antibodies/immunology , Antibodies/isolation & purification , Immunization , Receptor, Melatonin, MT1/biosynthesis , Receptor, Melatonin, MT1/immunology , Animals , CHO Cells , Cricetulus , HEK293 Cells , Humans , Mice , Mice, Inbred C57BL
7.
J Reprod Immunol ; 92(1-2): 54-61, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21963392

ABSTRACT

Daily variation in the peripheral level of melatonin plays a major role in integrating reproduction and environmental information for seasonally breeding birds. However, the variation in immunity and reproduction has never been assessed in any avian species on a 24 h time scale. Therefore, to understand the relationship between immune function and reproductive phases in a seasonally breeding bird, Perdicula asiatica, the Indian jungle bush quail, we studied the daily variation of melatonin and testosterone levels along with expression of their receptors Mel(1a), Mel(1b), and androgen receptor in the spleen during the reproductively active phase. Immunocytochemistry for the melatonin receptors Mel(1a) and Mel(1b) presented a differential distribution pattern. Western blot of splenic protein suggested a daily rhythm of melatonin receptors, while acrophases for the two melatonin receptors Mel(1a) and Mel(1b) differed by 4 h, suggesting that the expression of the receptors may peak at different times, causing more of either Mel(1a) or Mel(1b) to be available at a particular time to mediate function. The circulatory melatonin level correlated with percentage stimulation ratio of splenocytes and plasma interleukin-2 level, but did not correlate with testosterone or androgen receptor, suggesting that melatonin could be a major hormone imparting a time-of-day effect on the modulation of immune function in a seasonally breeding bird during the reproductively active phase.


Subject(s)
Immunity , Melatonin/metabolism , Receptor, Melatonin, MT1/metabolism , Receptor, Melatonin, MT2/metabolism , Reproduction , Animals , Chronobiology Phenomena/immunology , Coturnix , Environmental Exposure/adverse effects , Immunohistochemistry , Interleukin-2/blood , Melatonin/genetics , Melatonin/immunology , Receptor, Melatonin, MT1/genetics , Receptor, Melatonin, MT1/immunology , Receptor, Melatonin, MT2/genetics , Receptor, Melatonin, MT2/immunology , Receptors, Androgen/genetics , Receptors, Androgen/immunology , Receptors, Androgen/metabolism , Reproduction/physiology , Seasons , Spleen/immunology , Spleen/metabolism , Testosterone/genetics , Testosterone/immunology , Testosterone/metabolism
8.
Scand J Immunol ; 71(6): 420-30, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20500694

ABSTRACT

An inverse relation exists between melatonin and androgen in most of the seasonally breeding rodents, but the regulation of their receptors in modulation of immune function has never been reported. The present study accessed the expression pattern of melatonin receptor types (mt1R & mt2R), immune parameters (lymphoid organs weight, leucocyte count, delayed type hypersensitivity and lymphocyte proliferation) in spleen and thymus whereas androgen receptor (AR) expression in thymus of Funambulus pennanti during reproductively active phase. In-vivo melatonin treatment (Mel) and castration (Cx) significantly increased mt1R expression, immune parameters in spleen and thymus but decreased AR expression in thymus only when compared with sham control (Con) squirrels as AR expression was not observed in spleen. Mel alone or in combination with testosterone (T) to Cx squirrels significantly increased mt1R expression, immune parameters in spleen and thymus but decreased AR expression in thymus. T alone in Cx squirrels significantly decreased mt1R expression, immune parameters in spleen and thymus but increased thymic AR expression significantly. In-vitro thymocyte culture supported our in-vivo findings. Mel significantly increased mt1R expression, lymphocyte proliferation, IL-2 secretion but decreased AR expression. T alone significantly decreased aforementioned three parameters but increased AR expression. Combined treatment of Mel and T bring back all parameters to control level. Though we found high mt2R expression, but no significant change has been observed. Thus, present study suggests a clear-cut trade-off relation between mt1R and AR expression that might be acting as an important mediator in seasonal adjustment of immune function in tropical rodents.


Subject(s)
Receptor, Melatonin, MT1/biosynthesis , Receptor, Melatonin, MT2/biosynthesis , Receptors, Androgen/biosynthesis , Reproduction/immunology , Sciuridae/immunology , Animals , Blotting, Western , Enzyme-Linked Immunosorbent Assay , Hypersensitivity, Delayed/immunology , Immunity, Cellular/immunology , Interleukin-2/immunology , Interleukin-2/metabolism , Leukocyte Count , Lymphoid Tissue/immunology , Male , Melatonin/pharmacology , Receptor, Melatonin, MT1/immunology , Receptor, Melatonin, MT2/immunology , Receptors, Androgen/immunology , Sciuridae/metabolism , Seasons , Testosterone/pharmacology , Tropical Climate
SELECTION OF CITATIONS
SEARCH DETAIL
...